Lin L - Search Results

1

Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.

Chen SL, Ye F, Zhang JJ, Zou JJ, Qian XS, Li F, Yang S, Ge Z, Shan SJ, Li XB, Xu T, Kan J, Lin L, Han YL. Chen SL, et al. Among authors: lin l. Cardiovasc Ther. 2013 Aug;31(4):193-200. doi: 10.1111/j.1755-5922.2012.00319.x. Cardiovasc Ther. 2013. PMID: 22954234 Free article. Clinical Trial.

2

Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention.

Zou JJ, Xie HG, Chen SL, Tan J, Lin L, Zhao YY, Xu HM, Lin S, Zhang J, Wang GJ. Zou JJ, et al. Among authors: lin s, lin l. Eur J Clin Pharmacol. 2013 Apr;69(4):771-7. doi: 10.1007/s00228-012-1392-5. Epub 2012 Sep 22. Eur J Clin Pharmacol. 2013. PMID: 23001453 Clinical Trial.

3

Quantitative assessment of late lumen loss after biodegradable polymer and permanent polymer sirolimus-eluting stents implantation.

Kan J, Chen F, Liu LY, Xu HM, Lin L, Liu Y, Zhao YY, Cheng JP, Chen SL. Kan J, et al. Among authors: lin l. Chin Med J (Engl). 2013 Mar;126(6):1081-5. Chin Med J (Engl). 2013. PMID: 23506582

4

A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial.

Gao RL, Xu B, Lansky AJ, Yang YJ, Ma CS, Han YL, Chen SL, Li H, Zhang RY, Fu GS, Yuan ZY, Jiang H, Huo Y, Li W, Zhang YJ, Leon MB; TARGET I Investigators. Gao RL, et al. EuroIntervention. 2013 May 20;9(1):75-83. doi: 10.4244/EIJV9I1A12. EuroIntervention. 2013. PMID: 23685298 Free article. Clinical Trial.

5

[Comparison of short- and long-term outcome after percutaneous transluminal interventional therapy in octogenarians with coronary artery disease from radial or femoral approach].

You W, Ye F, Chen SL, Zhang JJ, Tian NL, Lin S, Liu ZZ, Wang R, Kan J, Xu T, Liu LL, Lin L, Xu HM. You W, et al. Among authors: lin s, lin l. Zhonghua Xin Xue Guan Bing Za Zhi. 2013 Sep;41(9):736-9. Zhonghua Xin Xue Guan Bing Za Zhi. 2013. PMID: 24331799 Chinese.

6

Increased risk for developing major adverse cardiovascular events in stented Chinese patients treated with dual antiplatelet therapy after concomitant use of the proton pump inhibitor.

Zou JJ, Chen SL, Tan J, Lin L, Zhao YY, Xu HM, Lin S, Zhang J, Fan HW, Xie HG. Zou JJ, et al. Among authors: lin s, lin l. PLoS One. 2014 Jan 8;9(1):e84985. doi: 10.1371/journal.pone.0084985. eCollection 2014. PLoS One. 2014. PMID: 24416326 Free PMC article.

7

Interleukin-6, but not C-reactive protein, predicts the occurrence of cardiovascular events after drug-eluting stent for unstable angina.

Chen SL, Liu Y, Lin L, Ye F, Zhang JJ, Tian NL, Zhang JX, Hu ZY, Xu T, Li L, Xu B, Latif F, Nguyen T. Chen SL, et al. Among authors: lin l. J Interv Cardiol. 2014 Apr;27(2):142-54. doi: 10.1111/joic.12103. Epub 2014 Mar 4. J Interv Cardiol. 2014. PMID: 24588086 Free article.

8

Association of the use of amlodipine with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention.

Liu XQ, Lin S, Qiu LL, Lin L, Zhao YY, Xu HM, Zhang J, Zou JJ. Liu XQ, et al. Among authors: lin s, lin l. Pharmazie. 2014 Nov;69(11):814-7. Pharmazie. 2014. PMID: 25985576

9

Coronary Artery Intraplaque Microvessels by Optical Coherence Tomography Correlate With Vulnerable Plaque and Predict Clinical Outcomes in Patients With Ischemic Angina.

Xu T, Lin L, Chen M, Zhang JJ, Ye F, Pan T, Huang X, Chen SL. Xu T, et al. Among authors: lin l. JACC Cardiovasc Interv. 2018 Jul 23;11(14):1421-1422. doi: 10.1016/j.jcin.2018.02.011. JACC Cardiovasc Interv. 2018. PMID: 30025740 Free article. No abstract available.

10

Intravascular Ultrasound vs Angiography-Guided Drug-Coated Balloon Angioplasty: The ULTIMATE Ⅲ Trial.

Gao XF, Ge Z, Kong XQ, Chen X, Han L, Qian XS, Zuo GF, Wang ZM, Wang J, Song JX, Lin L, Pan T, Ye F, Wang Y, Zhang JJ, Chen SL; ULTIMATE Ⅲ Investigators. Gao XF, et al. Among authors: lin l. JACC Cardiovasc Interv. 2024 Jul 8;17(13):1519-1528. doi: 10.1016/j.jcin.2024.04.014. Epub 2024 Jun 5. JACC Cardiovasc Interv. 2024. PMID: 38842991 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,037 results

Search Page

Filters